Skip to main content

Table 1 Opioid users under treatment with sublingual buprenorphine in the northeastern states of Manipur and Nagaland, India

From: Opioid substitution treatment with sublingual buprenorphine in Manipur and Nagaland in Northeast India: what has been established needs to be continued and expanded

Name of NGO Target Waitlist Currently under treatment Primary drug of use HIV testing and ART treatment
    Total Females (%) Heroin or brown sugar Dextropropoxyphene Combination HIV status known Ref for VCCT Ref for ART
Manipur           
Care Foundation (Imphal) 100 51 91 3 (3.3%) 80 (87.9%) 11 (12.1%) 0 (0%) 49 (53.8%) 56 (61.5%) 7 (7.7%)
Care Foundation (Nambol) 75 0 60 1 (1.7%) 31(51.7%) 25 (41.7%) 4 (6.7%) 9 (15%) 35 (58.3%) 0 (0%)
DPU 75 25 94 3 (3.2%) 63 (67%) 0 (0%) 31 (33%) 24 (25.5%) 24 (25.5%) 2 (2.1%)
MNP+ 100 150 102 0 (0%) 80 (78.4%) 7 (68.6%) 15 (14.7%) 65 (63.7%) 32 (31.4%) 9 (8.8%)
Ramungo Library 75 0 77 0 (0%) 4 (5.2%) 4 (5.2%) 69 (89.6%) 6 (7.8%) 21(27.3%) 2 (2.6%)
SASO (East) 100 30 100 0 (0%) 61 (61%) 4 (4%) 35 (35%) 32 (32%) 15 (15%) 1 (1%)
SASO (West) 100 27 100 2 (2%) 72 (72%) 10 (10%) 18 (18%) 26 (26%) 19 (19%) 6 (6%)
Sahara 100 0 110 7 (6.4%) 101(91.8%) 4 (3.7%) 5 (4.5%) 44 (40%) 35 (31.8%) 23 ((20.9%)
SHALOM 100 0 110 7 (6.4%) 68 (61.8%) 12 (10.9%) 30 (27.3%) 2 (1.8%) 23 (20.9%) 9 (8.2%)
Manipur Total 825 283 844 23 (2.7%) 560 (66.4%) 77 (9.1%) 207 (24.5%) 257 (30.5%) 260 (30.8%) 59 (7%)
Nagaland           
Bethesda (IDU) 100 168 114 0 (0%) 0 (0%) 1 (0.9%) 113 (99.1%) 3 (2.6%) 15 (13.2%) 0 (0%)
Bethesda (IDUSW) 100 0 106 79 (73.1%) 16 (15.1%) 12 (11.3%) 78 (73.6%) 13 (12.3%) 12 (11.3%) 0 (0%)
Bethesda- Pfutsero 75 0 60 0 (0%) 0 (0%) 54 (90%) 6 (10%) 0 (0%) 0 (0%) 0 (0%)
Kripa Foundation 100 0 124 0 (0%) 31(25%) 93 (75%) 0 (0%) 0 (0%) 11 (8.9%) 0 (0%)
Nagaland Total 375 168 404 79 (19.6%) 47 (11.6%) 160 (39.6%) 197 (48.8%) 16 (4%) 38 (9.4%) 0 (0%)
Grand Total 1200 451 1248 102 (8.2%) 607 (48.6%) 237 (19%) 404 (32.4%) 273 (21.9%) 298 (23.9%) 59 (4.7%)